ICMR is accepting applications from vaccine makers to develop its anti-serum against Covid-19

New Delhi: Indian Council of Medical Research (ICMR) is accepting applications from vaccine makers for developing and scaling up the ‘equine antiserum’ against Coronavirus. The equine antiserum was isolated by the National Institute of Virology in Pune earlier this year.

Also Read: “Better to die of Coronavirus than of hunger”: UP workers returning back to work

Commonly used to develop vaccines, the equine sera uses antibodies from horses for protection against diseases. Antiserum is a blood serum with antibodies against a virus. Antiserums are injected to protect humans against an infection or treat it.

Common examples of anti-sera are the “anti-rabies, anti-tetanus and anti-venom used against snake bites.”

Also Read: Zomato employees burn T-shirts to protest against Galwan Valley clash

ICMR is now inviting applications from vaccine developers to make the equine antiserum for use against SARS-Cov-2 virus. For this, the apex medical research body will grant a non-exclusive licence to the manufacturer along with a royalty of 5% on sales, says a recent report.

The post ICMR is accepting applications from vaccine makers to develop its anti-serum against Covid-19 appeared first on Prag News.

from Prag News https://ift.tt/2VkpImr
via IFTTT